Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone cluster 1, H2B pseudogene 3 (H2BP3) is classified as a pseudogene—a non-functional copy of a gene related to the histone H2B family. Pseudogenes such as H2BP3 possess sequence similarity to functional histone H2B genes but have accumulated mutations (e.g., frame shifts, codon changes, loss of regulatory sequences) that prevent them from encoding a functional histone protein[3][5]. Pseudogenes do not have known roles as therapeutic targets, enzymes, receptors, or other typical molecular drug targets. There is no evidence for an active biological function, disease association, or drug interaction regarding H2BP3. Its inclusion in databases as a target likely reflects confusion with functional histone H2B proteins, which are essential chromatin components, but H2BP3 itself does not encode a biologically active product[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone cluster 1, H2B pseudogene 3 (H2BP3).